A combined systemic inflammation score for predicting long-term mortality in patients admitted to the intensive cardiovascular care unit

Background Systemic inflammation contributes to the development of cardiovascular disease, but whether admission inflammatory biomarker levels predict long-term prognosis in critically ill cardiac patients remains debated. Methods We conducted a large, single-center observational study of consecutive ICCU admissions (January 2020–December 2021). Six biomarkers were evaluated for their ability to predict long-term all-cause mortality (median follow-up 4.7 years in the derivation cohort and 3.2 years in the validation cohort): neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), C-reactive protein-to-albumin ratio (CAR), fibrinogen-to-albumin ratio index (FARI), and immature platelet fraction (IPF). Optimal cutoffs were derived with receiver operating characteristic (ROC) analysis and the Youden index, and were then tested in an independent temporal validation cohort from the same center (2022 ICCU admissions). A composite score was built from the markers that remained significant in multivariable analysis. Results The derivation cohort included 2,131 patients and the validation cohort 1,013. Higher admission levels of most biomarkers were associated with higher long-term mortality. After multivariable adjustment, NLR (HR 1.68), SII (HR 1.40), CAR (HR 1.94), and FARI (HR 1.72) remained independent predictors of long-term mortality, beyond traditional risk factors. The composite score showed stepwise risk separation in unadjusted analysis; after adjustment, only scores of 3 and 4 remained independently associated with mortality (HR 2.58 and 3.31, respectively). Conclusions Elevated admission levels of NLR, SII, CAR, and FARI independently predicted long-term mortality in ICCU patients and may help refine risk assessment before discharge. A composite score based on these markers identified patients at the highest risk, but it did not reliably separate intermediate-risk groups. Further prospective studies, including external validation, are warranted.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-18
DOI
https://doi.org/10.3389/fcvm.2026.1880301
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A combined systemic inflammation score for predicting long-term mortality in patients admitted to the intensive cardiovascular care unit

Ari Naimark, Noam Fink, Ziv Dadon, Amjad Abu-Salman et al.
5 links
Frontiers in Cardiovascular Medicine
Inflammatory Biomarkers in Disease Prognosis
article

A combined systemic inflammation score for predicting long-term mortality in patients admitted to the intensive cardiovascular care unit

Ari Naimark, Noam Fink, Ziv Dadon, Amjad Abu-Salman, Abed Qadan, Nour Karra, Michael Glikson, Mamas A. Mamas, Elad Asher, Mohammad Karmi, Pierre François Sabouret, Netanel Zacks, Louay Taha, Dana Deeb, Dov Gavish, Akiva Brin, Rafel Hitter, Hila Gerard, Rana Al Hamori
article en

Abstract

Background Systemic inflammation contributes to the development of cardiovascular disease, but whether admission inflammatory biomarker levels predict long-term prognosis in critically ill cardiac patients remains debated. Methods We conducted a large, single-center observational study of consecutive ICCU admissions (January 2020–December 2021). Six biomarkers were evaluated for their ability to predict long-term all-cause mortality (median follow-up 4.7 years in the derivation cohort and 3.2 years in the validation cohort): neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), C-reactive protein-to-albumin ratio (CAR), fibrinogen-to-albumin ratio index (FARI), and immature platelet fraction (IPF). Optimal cutoffs were derived with receiver operating characteristic (ROC) analysis and the Youden index, and were then tested in an independent temporal validation cohort from the same center (2022 ICCU admissions). A composite score was built from the markers that remained significant in multivariable analysis. Results The derivation cohort included 2,131 patients and the validation cohort 1,013. Higher admission levels of most biomarkers were associated with higher long-term mortality. After multivariable adjustment, NLR (HR 1.68), SII (HR 1.40), CAR (HR 1.94), and FARI (HR 1.72) remained independent predictors of long-term mortality, beyond traditional risk factors. The composite score showed stepwise risk separation in unadjusted analysis; after adjustment, only scores of 3 and 4 remained independently associated with mortality (HR 2.58 and 3.31, respectively). Conclusions Elevated admission levels of NLR, SII, CAR, and FARI independently predicted long-term mortality in ICCU patients and may help refine risk assessment before discharge. A composite score based on these markers identified patients at the highest risk, but it did not reliably separate intermediate-risk groups. Further prospective studies, including external validation, are warranted.

Frontiers in Cardiovascular MedicineVol. 13
Ben-Gurion University of the Negev (IL), Hebrew University of Jerusalem (IL), Sheba Medical Center (IL), Assuta Medical Center (IL), Shaare Zedek Medical Center (IL), Bikur Cholim Hospital (IL), Sorbonne Université (FR), Pitié-Salpêtrière Hospital (FR), Keele University (GB)
Good health and well-being
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon